Related Experiment Videos

[Chronic kidney disease and statins]

Mirjana Sabljar Matovinović1

  • 1Klinika za unutarnje bolesti, Klinicka bolnica "Merkur", Zagreb. mirjana.sabljar-matovinovic@zg.htnet.hr

Lijecnicki Vjesnik
|January 11, 2007
PubMed

Insights

Dyslipidemia increases the risk of developing kidney disease and worsens its progression. Statin therapy shows promise in reducing cardiovascular risk and slowing chronic kidney disease (CKD) progression, particularly in moderate stages.

Area of Science:

  • Nephrology
  • Cardiology
  • Endocrinology

Context:

  • Dyslipidemia is a significant risk factor for the initial development and progression of kidney disease.
  • Chronic kidney disease (CKD) and dyslipidemia frequently coexist, both independently increasing cardiovascular disease (CVD) risk.
  • A strong correlation exists between the severity of renal insufficiency and cardiovascular disease incidence.

Purpose:

  • To evaluate the role of statin therapy in managing cardiovascular risk and disease progression in patients with CKD.
  • To investigate the efficacy of statins in modifying the course of kidney disease, especially in those with moderate renal impairment.

Summary:

  • Dyslipidemia contributes to new-onset renal disease and accelerates functional decline in diabetic and non-diabetic kidney disease.
  • Statin therapy is suggested to reduce cardiovascular risk and potentially alter CKD progression, particularly in moderate renal impairment.
  • Further large-scale trials are required to confirm the benefits of statins across various stages of renal insufficiency.

Impact:

  • Statin therapy may offer a therapeutic strategy to mitigate cardiovascular complications in CKD patients.
  • Understanding the impact of statins on CKD progression could lead to improved patient outcomes and reduced healthcare burden.
  • Ongoing trials are crucial for establishing definitive guidelines on statin use in managing CKD and its associated cardiovascular risks.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...